Trials / Completed
CompletedNCT01221922
Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI
A Study of the RevLite Q-Switched Neodymium: Yttrium-Aluminum-Garnet (Nd:YAG) Laser for the Treatment of Acne Scars in Fitzpatrick Skin Types III-VI
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- ConBio, a Cynosure Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the RevLite Q-Switched Neodymium: Yttrium-Aluminum-Garnet (Nd:YAG) Laser in the treatment of acne scars in darker skin types (Fitzpatrick Skin Types III, IV, V and VI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RevLite Q-Switched Nd:YAG Laser | Laser treatment once every 2 weeks for a total of 10 treatments. |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-10-18
- Last updated
- 2012-11-28
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01221922. Inclusion in this directory is not an endorsement.